EP PerMed - the European Partnership for Personalised Medicine

What EP PerMed - the European Partnership for Personalised Medicine does

EP PerMed — the European Partnership for Personalised Medicine — is a publicly funded European research partnership launched in 2023 and coordinated from Bonn by DLR Projektträger (the project management agency of the German Aerospace Center). It operates under EU Horizon Europe grant agreement No 101137129 with a ten-year budget of approximately €375 million (2023–2033), co-funded by the European Commission and more than 50 international partners spanning 24 countries and 10 European regions. The partnership succeeds the ERA PerMed ERA-Net Cofund and consolidates more than fifteen years of European collaboration on personalised medicine under a single, broader mandate that explicitly covers research, innovation, and implementation.

The partnership's core activities centre on Joint Transnational Calls (JTC) — competitive, co-funded mechanisms that channel resources to multi-country research consortia. Under JTC2024 alone, 38 funding organisations from 23 countries pooled €39.2 million to fund 27 consortia (154 research groups), selected from 283 eligible pre-proposals. Beyond funding calls, EP PerMed maintains a Project Database, hosts an annual conference jointly with ICPerMed, runs educational programmes (Summer Schools, Implementation Schools, hackathons, workshops), publishes the Strategic Research and Innovation Agenda (SRIA) and policy compendia, and operates the "Science of You" podcast. Operational deliverables include regional Round Tables, a Citizen Awareness Survey, and a Video Competition for young investigators.

EP PerMed does not commercialise products or services; its funding is grant-based from the EU and participating national funders, with no pricing tiers, equity, or traditional customer relationships. Its stakeholder base spans academic researchers, university medical centres and clinicians, pharmaceutical and diagnostics industry, patient organisations, ministries and regulatory authorities, and European research infrastructures (notably BBMRI-ERIC for biobanking). The model is event-driven: funding cycles, conferences, schools, and publications drive engagement rather than sales motions, and there are no hiring signals indicative of rapid internal expansion — the permanent coordination unit comprises approximately seven staff hosted by DLR Projektträger.

Name

EP PerMed - the European Partnership for Personalised Medicine

Legal name

Deutsches Zentrum für Luft- und Raumfahrt e.V. (DLR)

Website

https://eppermed.eu

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

EP PerMed is a publicly funded European partnership coordinating personalised medicine research across 24 countries. Under EU Horizon Europe with a €375 million ten-year budget, it funds transnational consortia, runs joint calls and conferences, and serves researchers, clinicians, policymakers, and patients.

Ownership category

akta.pro rank

Product category

Research Partnership Coordination

NAICS

Scientific Research and Development Services (5417), Research and Development in the Social Sciences and Humanities (54172)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Personalised medicine research
• Transnational research funding
• Biomedical research coordination
• Clinical research collaboration
• Health innovation partnership

Headquarters

HQ city

Bonn

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. EU Horizon Europe Funding: EP PerMed receives direct funding from the European Union's Horizon Europe research and innovation programme under grant agreement No 101137129. This provides core funding for partnership operations, coordination, and co-funded research projects.
2. International Partner Contributions: More than 50 international partners from 24 countries and 10 European regions contribute funding to the partnership, providing additional resources for transnational research projects and collaborative activities over the 2023-2033 period.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

EP PerMed coordinates and co-funds transnational personalised medicine research across Europe by running joint transnational calls (JTC) and educational programmes (Summer Schools, Implementation Schools), and by aligning stakeholders through strategic documents (SRIA), round tables, conferences, and a public project database. Its offering is directed at researchers, clinicians, healthcare providers, industry, patients, and national funding agencies in 24 countries and 10 European regions.

Product overview

EP PerMed is a European partnership platform (not a single unified software product) that coordinates and funds personalised medicine research across Europe. The core offering consists of Joint Transnational Calls (JTC) for funding proposals, supported by a Project Database of funded projects. The platform extends through educational programmes including EP PerMed Schools (Summer Schools, Implementation Schools), Workshops & Trainings, and Round Tables for regional dialogue. EP PerMed also produces The Science of You podcast, maintains a Personalised Medicine Resources library, publishes a regular Newsletter, and organizes large-scale Conferences. The SRIA (Strategic Research & Innovation Agenda) guides priorities, while initiatives like the Citizen Awareness Survey and Video Competition engage the broader community.

Differentiator

Problem solved

Functional benefit

Products and services

• Joint Transnational Calls (JTC) Competitive, co-funded calls inviting transnational research consortia to submit proposals for personalised medicine research; results are published via the EP PerMed project database. Target users are academic and clinical research groups in participating countries.
• EP PerMed Educational Programmes (Summer Schools & Implementation Schools) Training programmes that build capacity in personalised medicine research and implementation, aimed at early-career researchers, clinicians, and other stakeholders.
• EP PerMed Conferences, Round Tables, Workshops and Trainings Events that bring together researchers, clinicians, industry, patients, and policymakers to align priorities and disseminate findings in personalised medicine.
• Strategic Research and Innovation Agenda (SRIA) Strategic document defining the priorities, roadmaps, and expected impacts of EP PerMed's research and innovation activities, used to align call topics and stakeholder activities.

Quantifiable outcome

• €39.2 million invested across 27 funded research consortia under JTC2024
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core, major and supporting.

• DLR Projektträger (German Aerospace Center)coreStrategic or Co-development Partner · 1 January 2023DLR Projektträger serves as the coordinating body for EP PerMed. The agency manages the partnership's operations, coordinates funding activities, organises calls for proposals, and provides administrative support for the partnership under the direction of Dr Wolfgang Ballensiefen as Coordinator.
• ERA PerMedcoreStrategic or Co-development PartnerERA PerMed is the predecessor initiative to EP PerMed. EP PerMed builds on ERA PerMed's results, experience, and established collaborative networks. Many partners involved in ERA PerMed continue their engagement through EP PerMed.
• ICPerMed (International Consortium for Personalised Medicine)coreStrategic or Co-development PartnerICPerMed is an international coordination platform that expands the personalised medicine network beyond Europe. EP PerMed works closely with ICPerMed, including joint conferences and aligned activities to maximise global impact and knowledge sharing in personalised medicine.
• DLR ProjektträgercoreImplementation/ SI/ Consulting PartnerAs the project management agency, DLR Projektträger provides professional project management services including call management, proposal evaluation, consortium coordination, reporting, and dissemination support for EP PerMed activities.
• BBMRI-ERICmajorStrategic or Co-development PartnerBBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure) is a European research infrastructure for biobanks. EP PerMed collaborates with BBMRI-ERIC on issues related to biobank data, participant return of results, and ethical frameworks for personalised medicine research.
• EIT HealthmajorStrategic or Co-development PartnerEIT Health is a European health innovation network. EP PerMed has partnered with EIT Health on specific initiatives including round table discussions on de-risking innovation in personalised medicine, leveraging EIT Health's industry connections and innovation ecosystem expertise.
• Toscana Lifescience FoundationsupportingImplementation/ SI/ Consulting PartnerPartnered with EP PerMed in organising the first EP PerMed Summer School on Innovation, Technology Transfer and Entrepreneurship in Personalised Medicine held in Palermo, Italy in June 2025.
• Telethon FoundationsupportingImplementation/ SI/ Consulting PartnerCollaborated with EP PerMed in organising the first EP PerMed Summer School on Innovation, Technology Transfer and Entrepreneurship in Personalised Medicine.
• University of PalermosupportingStrategic or Co-development PartnerHosted a dedicated programme session for the EP PerMed Summer School 2025 in the historic hall of the University of Palermo, demonstrating academic collaboration in educational activities.
• 38 National and Regional Funding OrganisationscoreStrategic or Co-development PartnerFunding organisations from 23 countries participate in EP PerMed joint transnational calls, providing national and regional co-funding for approved research consortia. These partners include ministries, national research councils, and regional funding agencies that ensure the transnational nature of the funded research.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• European Molecular Biology Laboratory (EMBL): Intergovernmental research organisation in molecular life sciences with member states across Europe. Comparable as a long-standing European life sciences coordination entity that supports translational research relevant to personalised medicine.
• NIH (National Institutes of Health): Largest public funder of biomedical research globally, with significant personalised medicine programmes (e.g., All of Us). Comparable as a public-sector research funding and coordination body, though operating at a different geographic and scale level than EP PerMed.
• EIT Health: Larger European health innovation network (Knowledge and Innovation Community under EIT) that EP PerMed partners with on innovation and de-risking initiatives. Comparable as a major European health partnership coordinating research, education, and innovation.
• Innovative Health Initiative (IHI): Successor to the Innovative Medicines Initiative (IMI), IHI is a large-scale public-private partnership under Horizon Europe. Comparable as a major EU co-funded health partnership facilitating cross-sector collaboration, though with a broader therapeutic scope than personalised medicine alone.
• Cancer Mission (EU Mission on Cancer): Horizon Europe Mission focused on cancer with substantial personalised medicine components. Comparable as a major EU-funded initiative coordinating research and implementation across member states with significant overlap in stakeholder community.

Direct peers

• ICPerMed (International Consortium for Personalised Medicine): International coordination platform for personalised medicine that EP PerMed partners with for joint conferences and aligned activities. Directly comparable as a strategic coordination and policy-shaping body for personalised medicine at a global level.
• ERA PerMed: Direct predecessor to EP PerMed, ERA PerMed was the ERA-Net Cofund action (2017-2023) that funded transnational personalised medicine research across European countries. It is directly comparable because EP PerMed explicitly inherits its mandate, networks, and operational model.
• European Joint Programme on Rare Diseases (EJP RD): EU-funded partnership coordinating rare diseases research funding and infrastructure across European countries. Directly comparable as a transnational Horizon Europe partnership using joint calls to coordinate national funding organisations.

Emerging players

• Global Alliance for Genomics and Health (GA4GH): International standards-setting organisation for genomics and health data sharing. Comparable as a coordinating body building frameworks and standards that enable personalised medicine research globally, with overlapping stakeholders in genomics policy and data governance.
• BBMRI-ERIC: European research infrastructure for biobanking that collaborates with EP PerMed on biobank data, participant return of results, and ethical frameworks. Comparable as a European-level life sciences infrastructure entity supporting personalised medicine research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UClB3RGJEACsFM7Lm6pLBfJw
• LinkedInlinkedin.com/company/ep-permed
• Xtwitter.com/EPPerMed

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EP PerMed - the European Partnership for Personalised Medicine